Journal ID (nlm-ta): Rheumatology (Oxford)
Journal ID (iso-abbrev): Rheumatology (Oxford)
Journal ID (publisher-id): brheum
Title:
Rheumatology (Oxford, England)
Publisher:
Oxford University Press
ISSN
(Print):
1462-0324
ISSN
(Electronic):
1462-0332
Publication date
(Print):
April
2019
Publication date
(Electronic):
04
December
2018
Publication date PMC-release: 04
December
2019
Volume: 58
Issue: 4
Pages: 636-644
Affiliations
[1
]Division of Rheumatology, Hôpital Maisonneuve-Rosemont, Montreal, Quebec, Canada
[2
]Department of Medicine, McGill University, Montreal, Quebec, Canada
[3
]Division of Rheumatology, Jewish General Hospital, Montreal, Quebec, Canada
[4
]Lady Davis Institute, Jewish General Hospital, Montreal, Quebec, Canada
[5
]Rheumatology Unit, Royal Adelaide Hospital, Adelaide, Australia
[6
]Discipline of Medicine, University of Adelaide, Adelaide, South Australia
[7
]Department of Rheumatology, St Vincent’s Hospital, Melbourne, Victoria, Australia
[8
]Department of Medicine, University of Melbourne at St Vincent’s Hospital, Melbourne,
Victoria, Australia
Author notes
Correspondence to: Murray Baron, Division of Rheumatology, Jewish General Hospital,
A.725-3755 chemin de la Côte-Sainte-Catherine, Montreal, Quebec H3T 1E2, Canada. E-mail:
mbaron@
123456jgh.mcgill.ca
Author information
Article
Accession ID: PMC6434374
Pmcid ID: PMC6434374
Pmc-uid ID: 6434374
Publisher ID:
key350
DOI: 10.1093/rheumatology/key350
PMC ID: 6434374
PubMed ID: 30517716
SO-VID: ad480db5-24e7-4b2e-ab90-1b33c95f1a23
Copyright © © The Author(s) 2018. Published by Oxford University Press on behalf of the British
Society for Rheumatology. All rights reserved. For permissions, please email: journals.permissions@oup.com
License:
This article is published and distributed under the terms of the Oxford University
Press, Standard Journals Publication Model (
https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model)
Funded by:
Canadian Scleroderma Research Group
Funded by:
CSRG
Funded by:
Canadian Institutes of Health Research
10.13039/501100000024
Award ID: #FRN 83518
Funded by:
CIHR
10.13039/501100000024
Funded by:
Scleroderma Society of Canada
Funded by:
Scleroderma Society of Ontario
Funded by:
Scleroderma Society of Saskatchewan
Funded by:
Sclérodermie Québec
Funded by:
Cure Scleroderma Foundation
Funded by:
INOVA Diagnostics Inc
Funded by:
Pfizer
10.13039/100004319
Funded by:
Actelion pharmaceuticals
Funded by:
Fonds de la recherche du Québec – Santé
Funded by:
FRQS
10.13039/501100000156
Funded by:
Australian Scleroderma Interest Group (ASIG)
Funded by:
Scleroderma Australia
Funded by:
Scleroderma Victoria
Funded by:
Arthritis Australia
10.13039/501100000940
Funded by:
Actelion Australia
Funded by:
MOVE
10.13039/501100011578
Funded by:
The Australian Rheumatology Association
Funded by:
The Scleroderma Clinical Trials Consortium
Funded by:
St Vincent’s Hospital Research Endowment Fund
Funded by:
Bayer
10.13039/100004326
Funded by:
CSL Biotherapies
Funded by:
GlaxoSmithKline Australia
10.13039/501100001203
Funded by:
Roche
10.13039/100004337
Funded by:
Hôpital Maisonneuve Rosemont Department of Medicine Foundation
Funded by:
Fonds de la recherche du Québec – Santé
Funded by:
FRQS
10.13039/501100000156
Funded by:
National Health and Medical Research Council of Australia
Award ID: APP 1126370